Nuvation Bio Inc.
NUVBNYSEHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $1.59B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $3.67$9.75
- Volume (live)
- -
- Avg. volume (3M)
- 5.48M
Nuvation Bio (NUVB) Stock Price & Financial Analysis
Nuvation Bio Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $4.44 - $4.66 |
|---|---|
| 52-Week High | $9.75 |
| 52-Week Low | $3.67 |
| Open | $4.62 |
| Volume (last close) | 3.19M |
| Average Volume (3M) | 5.48M |
| Revenue (TTM) | 169.90M |
|---|---|
| Net Income (TTM) | -149.83M |
| Free Cash Flow (TTM) | -128.93M |
| EPS (TTM) | −$0.43 |
| Profit Margin | -88.19% |
| Operating Margin | -81.00% |
| Return on Equity (ROE) | -59.02% |
| Debt to Equity | 0.98 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 1.59B |
|---|---|
| Shares Outstanding | 348.77M |
| Price to Sales (P/S) | 9.38 |
| Price to Book (P/B) | 6.28 |
| EV/EBITDA | -13.12 |
| 50-Day MA | $5.94 |
|---|---|
| 200-Day MA | $5.52 |
| 1-Year Change | +7.06% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Nuvation Bio at a Glance
As of the Oct 23, 2026 close, Nuvation Bio (NUVB) has a market capitalization of $1.59B. The stock trades at 9.4× sales. Over the trailing twelve months it lost $149.83M on revenue of $169.90M and burned $128.93M of free cash flow. Revenue grew 1083.6% year over year.
As of its latest reported balance sheet, it holds $258.60M in cash and securities against $248.52M of debt, a net cash position of $10.09M.
Nuvation Bio does not currently pay a dividend.
The share price is up 7.1% over the past year. At $4.57 (the Oct 23, 2026 close) it sits near the bottom of its 52-week range of $3.67 to $9.75, below its 200-day moving average of $5.52.
Based on 12 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $14.57, 218.8% above the Oct 23, 2026 close.
Frequently Asked Questions About Nuvation Bio
What is the current stock price for NUVB?
As of the Oct 23, 2026 close, NUVB stock trades at $4.57. The 52-week range is $3.67–$9.75, with a day range of $4.44–$4.66.
What is the P/E ratio for NUVB?
The P/E ratio (Price-to-Earnings) for NUVB is shown in the Key Statistics section. This valuation metric helps compare Nuvation Bio Inc. to industry peers.
Does NUVB pay dividends?
Nuvation Bio does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for NUVB?
Based on ratings from 12 professional analysts over the last 90 days, the consensus for NUVB is Buy. The average 12-month price target is $14.57, a 218.8% upside from the Oct 23, 2026 close of $4.57.
What is the market cap of NUVB?
As of the Oct 23, 2026 close, Nuvation Bio's market capitalization is $1.59B, classifying it as a small-cap company. Nuvation Bio operates in the Healthcare sector within the Biotechnology industry.